TY - JOUR
T1 - Groups potentially at risk for making poorly informed decisions about entry into clinical trials for childhood cancer
AU - Simon, Christian
AU - Zyzanski, Stephen J.
AU - Eder, Michelle
AU - Raiz, Pauline
AU - Kodish, Eric D.
AU - Siminoff, Laura A.
PY - 2003/6/1
Y1 - 2003/6/1
N2 - Purpose: Some patients may be at greater risk than others of enrolling on a randomized clinical trial (RCT) without fully understanding the implications. To investigate this possibility, this study poses the question, Do non-English-speaking Latino parents of children with leukemia show differences in their discussion of and understanding of an RCT when compared with English-speaking minority parents and with English-speaking majority (ie, white) parents? This research hypothesizes that factors such as social and educational status and the role of language interpreters may account for significant differences in the discussion and understanding of an RCT among the three groups. Patients and Methods: A total of 108 parents are reported on, all of whom were observed, interviewed, and audiotaped during informed-consent discussions about participation in an RCT with their child's oncologist. Comparisons among the groups were performed using χ2 tests and a one-way analysis of variance. Results: Problems of consent-related communication and understanding were more frequent among parents of low social status who spoke little or no English than they were in the two other groups. Several factors may have contributed to this disparity, including language interpretation, social status, and prevailing cultural norms. Conclusion: Some patients may be at greater risk than others of enrolling on an RCT without fully understanding the implications of their decision to do so. Numerous factors may contribute to this disparity, including language interpretation, social status, and prevailing cultural norms. Some specific strategies are suggested to help address this disparity.
AB - Purpose: Some patients may be at greater risk than others of enrolling on a randomized clinical trial (RCT) without fully understanding the implications. To investigate this possibility, this study poses the question, Do non-English-speaking Latino parents of children with leukemia show differences in their discussion of and understanding of an RCT when compared with English-speaking minority parents and with English-speaking majority (ie, white) parents? This research hypothesizes that factors such as social and educational status and the role of language interpreters may account for significant differences in the discussion and understanding of an RCT among the three groups. Patients and Methods: A total of 108 parents are reported on, all of whom were observed, interviewed, and audiotaped during informed-consent discussions about participation in an RCT with their child's oncologist. Comparisons among the groups were performed using χ2 tests and a one-way analysis of variance. Results: Problems of consent-related communication and understanding were more frequent among parents of low social status who spoke little or no English than they were in the two other groups. Several factors may have contributed to this disparity, including language interpretation, social status, and prevailing cultural norms. Conclusion: Some patients may be at greater risk than others of enrolling on an RCT without fully understanding the implications of their decision to do so. Numerous factors may contribute to this disparity, including language interpretation, social status, and prevailing cultural norms. Some specific strategies are suggested to help address this disparity.
KW - Analysis of Variance
KW - Child
KW - Clinical Trials as Topic
KW - Communication Barriers
KW - Decision Making
KW - Hispanic or Latino
KW - Humans
KW - Informed Consent
KW - Leukemia/therapy
KW - Parents
KW - Texas
UR - http://www.scopus.com/inward/record.url?scp=0037530503&partnerID=8YFLogxK
U2 - 10.1200/JCO.2003.03.003
DO - 10.1200/JCO.2003.03.003
M3 - Article
C2 - 12775743
AN - SCOPUS:0037530503
SN - 0732-183X
VL - 21
SP - 2173
EP - 2178
JO - Journal of Clinical Oncology
JF - Journal of Clinical Oncology
IS - 11
ER -